Skip to content

Clinical efficacy of focused extracorporeal shock wave therapy for rotator cuff injury and changes in functional brain network connectivity on chronic pain : a RCT study

Clinical efficacy of focused extracorporeal shock wave therapy for rotator cuff injury and changes in functional brain network connectivity on chronic pain : a RCT study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111302
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Injury

Interventions

Control group:Conventional rehabilitation + pharmacotherapy
Placebo group:Conventional rehabilitation + placebo ESWT
Experimental group:Conventional rehabilitation + active ESWT

Sponsors

Wuxi Ninth people's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-55 years; 2. Meeting the diagnostic criteria for Neer stage I and II rotator cuff injury according to the 2019 American Academy of Orthopaedic Surgeons (AAOS) clinical practice guidelines; 3. Rotator cuff injury was confirmed by magnetic resonance imaging, without full-thickness tear, and the duration of injury was more than 3 months; 4. No pain medication has been taken in the past 2 weeks, and no shock wave, intra-articular injection and other treatments have been performed within the last 3 months; 5. Have good cognitive function; 6. Patients volunteered to participate in this study and signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined with periarthritis of shoulder, rotator cuff calcifying tendinitis, other shoulder diseases, and shoulder with internal fixation; 2. Full-thickness rotator cuff tear; 3. Abnormal liver or kidney function, or cardiovascular and cerebrovascular diseases; 4. Contraindications to ultrasound examination or extracorporeal shock wave therapy; 5. Combined with infectious diseases; 6. Psychiatric diseases or severe cognitive dysfunction.

Design outcomes

Primary

MeasureTime frame
visual analogue scale, VAS;shoulder pain and disability index, SPADI;

Secondary

MeasureTime frame
active shoulder range of motion, AROM;Disability of the Arm, Shoulder and Hand, DASH;Hamilton Anxiety Scale, HAMA;Hamilton Depression Scale, HAMD;resting-state fMRI;hypersensitive C-reactive protein, hs-CRP;

Countries

China

Contacts

Public ContactYanwen Xu

Wuxi Ninth people's Hospital

xudeng2@163.com+86 139 2956 5787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026